Výsledky vyhledávání - "Sinead A. Noonan"

Cost and public reimbursement of cancer medicines in the UK and the Republic of Ireland

Autor: David, O'Reilly, Ronan, McLaughlin, Cian, Ronayne, Anne Marie, De Frein, Bojan, Macanovic, Ryan W, Chu, Sinead A, Noonan, Roisin M, Connolly, Derek G, Power, Richard M, Bambury, Seamus, O'Reilly, Dearbhaile Catherine, Collins

Publikováno v: Irish journal of medical science.

There are disparities in the availability of systemic anticancer therapies (SACTs) globally. We set out to investigate the cost and reimbursement of SACTs in the United Kingdom (UK) and the Republic of Ireland (ROI) in conjunction with efficacy and l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::17a5b53b90537e003312565c18fa951e
https://pubmed.ncbi.nlm.nih.gov/35449390

Zobrazit plný text záznamu

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status

Autor: William T. Purcell, Paul A. Bunn, Sinead A. Noonan, Laurie L. Carr, D. Ross Camidge, Robert C. Doebele, Dara L. Aisner, Tejas Patil

Publikováno v: Lung Cancer. 96:27-32

Introduction Peritoneal metastasis from lung cancer is an uncommon clinical event and there are limited data on what factors predict peritoneal progression. This study retrospectively investigated whether patterns of metastatic spread and oncogene st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df4c1f9e08d285b376a847673d5303b2
https://doi.org/10.1016/j.lungcan.2016.03.007

Zobrazit plný text záznamu

Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung

Autor: Anna E. Barón, D. Ross Camidge, Dexiang Gao, Xian Lu, Jessica R. Thibault, Robert C. Doebele, Paul A. Bunn, Gentry G. King, Sinead A. Noonan, W. Thomas Purcell, Tejas Patil

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(1)

Introduction The role of serum tumor markers in the modern management of advanced NSCLC remains poorly described. Methods A single-center retrospective analysis of available carcinoembryonic antigen, CA125, CA19.9, and CA27.29 levels at baseline and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75124dccf0483350d7e78caebdf2e21
https://pubmed.ncbi.nlm.nih.gov/28843358

Zobrazit plný text záznamu

Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap Analysis

Autor: Anna E. Barón, Dara L. Aisner, Jamie Sheren, Marileila Varella-Garcia, Patrick C. Chesnut, Sinead A. Noonan, Lynne D. Berry, Robert C. Doebele, Daniel T. Merrick, Dexiang Gao, Xian Lu, D. Ross Camidge

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(8)

Mesenchymal-epithelial transition factor gene (MET) gene copy number gain may be a predictive biomarker for mesenchymal-epithelial transition factor (MET) inhibition in lung cancer, but the most appropriate method and criteria for defining MET positi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979f4677460ca201cc493334933f46f5
https://pubmed.ncbi.nlm.nih.gov/27262212

Zobrazit plný text záznamu

PROFILE 1014: lessons for the new era of lung cancer clinical research

Autor: Sinead A, Noonan, D Ross, Camidge

Publikováno v: Translational lung cancer research. 4(5)

PROFILE 1014 compared crizotinib to up to six cycles of standard platinum-pemetrexed chemotherapy as the first line treatment of advanced anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC). Overall, PROFILE 1014 has taught

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::67b93a5d9183ce081aa0d8dfecc4c8d9
https://pubmed.ncbi.nlm.nih.gov/26629438

Zobrazit plný text záznamu

Impact of MET inhibitors on survival among patients (pts) with MET exon 14 mutant (METdel14) non-small cell lung cancer (NSCLC)

Autor: Sinead A. Noonan, Jeffrey W. Clark, Conor E. Steuer, Lynette M. Sholl, Sai-Hong Ignatius Ou, Daniel B. Costa, Viola W. Zhu, Alexander Drilon, Suzanne E. Dahlberg, Tony Mok, Sasha Kravets, D. Ross Camidge, Yoko Korenaga Fukuda, Shirish M. Gadgeel, Patrick M. Forde, Giulia Costanza Leonardi, Mark M. Awad, Pasi A. Jänne, Rebecca S. Heist

Publikováno v: Journal of Clinical Oncology. 35:8511-8511

8511 Background: Dramatic responses to MET inhibitors have been reported in patients with NSCLC harboring activating mutations that cause MET exon 14 ( METdel14) skipping. We conducted a multicenter retrospective analysis of pts with METdel14 NSCLC t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c84fec86621a2fa081a77efc364d3373
https://doi.org/10.1200/jco.2017.35.15_suppl.8511

Zobrazit plný text záznamu

Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment

Autor: Jacintha O'Sullivan, Monika Biniecka, Blathnaid Nolan, Aoife Maguire, Diarmuid O'Donoghue, Sinead Noonan, Miriam Tosetto, John Hyland, Hugh Mulcahy, David Fennelly, Shane O’Meachair, Maria E Morrissey, Kieran Sheahan, Petra Martin

Publikováno v: Oncotarget

// Sinead A. Noonan 1, * , Maria E. Morrissey 2, * , Petra Martin 1 , Monika Biniecka 3 , Shane O’Meachair 4 , Aoife Maguire 5 , Miriam Tosetto 1 , Blathnaid Nolan 1 , John Hyland 1 , Kieran Sheahan 1 , Diarmuid O’Donoghue 1 , Hugh Mulcahy 1 , Da

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac36d1b318a7c45594be165738aaf786
http://europepmc.org/articles/PMC5828217

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání